Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00437541
Other study ID # Insulation study
Secondary ID 01/06/068
Status Completed
Phase N/A
First received February 20, 2007
Last updated February 20, 2007
Start date July 2001
Est. completion date December 2002

Study information

Verified date February 2007
Source University of Otago
Contact n/a
Is FDA regulated No
Health authority New Zealand: Health Research Council
Study type Interventional

Clinical Trial Summary

In six communities we will seek out households where someone who has a history of respiratory problems. For the first winter we will measure temperature and humidity of the house and health of occupants. We will insulate half the houses and the next winter compare them with the uninsulated houses to see if warmer houses improve health.


Description:

Damp, cold indoor environments are bad for the health of people who live in them, particularly if they have respiratory problems or are vulnerable, such as the young or the very old. This is a community based study designed to test the hypothesis that insulating domestic houses will make them warmer and that this increase in indoor temperature will improve their health and wellbeing.

Following two pilot studies, the first among older people in city council flats and the second among home owners in Waitara. We have followed the "Waitara model" where community networks will be mobilised to identify households in each community where there is someone with a on going respiratory problem. Seven communities have been selected to help test these hypotheses and have agreed to participate Otara, Gisborne, Mahia/Nuhaka, Taranaki, Porirua, West Coast and Christchurch. Low income areas with high Maori populations have been deliberately selected to maximise the potential health gains.

Two hundred houses in each community will be insulated free of charge to the occupants. The workers who will insulate the homes will be local people employed through the Department of Work and Income (WINZ).

Once the houesholds are selected they will be randomly assigned to intervention or control groups. During the first winter, all 1400 households will be monitored for temperature and humidity and their comfort, health and healthcare utilization will be recorded. Half the households, assigned to the intervention group, will be fully insulated during the spring. The following winter, all the initial measurements taken from both the intervention and control group will be repeated. At the end of the study period, all control houses will be insulated.

This study has developed from a natural intervention being carried out by the Energy Efficiency Conservation Authority (EECA) to insulate domestic houses in New Zealand and is a major collaborative effort, which will shed light on the effectiveness of insulation in improving health and wellbeing. The impact of housing refurbishment on health has not previously been examined. There is considerable government and policy interest in promoting healthy housing and there is strong community interest in ensuring the housing stock is improved in order to lower health risks.


Recruitment information / eligibility

Status Completed
Enrollment 4000
Est. completion date December 2002
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Live in Study area

- At least one person in the household must had had respiratory illness within the last year, well members of the same household may also participate

- house currently uninsulated

- interested in taking part in research

Exclusion Criteria:

- Intending to move within study period

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Device:
Insulation retrofitted into house


Locations

Country Name City State
New Zealand Crown Public Health Christchurch
New Zealand Te Iwi O Rakaipaaka Mahia/Nuhaka East Coast
New Zealand Te Wahine O Kahungungu Mahia/Nuhaka East Coast
New Zealand Te Puni Kokiri New Plymouth Taranaki
New Zealand Opotiki Trade Training Opotiki Gisborne
New Zealand Otara Health Inc Otara Auckland
New Zealand Porirua Housing Action Group Porirua Wellington
New Zealand Maori Womans Welfare League Rata - Hokitika West Coast

Sponsors (1)

Lead Sponsor Collaborator
University of Otago

Country where clinical trial is conducted

New Zealand, 

References & Publications (1)

Howden-Chapman P, Crane J, Matheson A, Viggers H, Cunningham M, Blakely T, O'Dea D, Cunningham C, Woodward A, Saville-Smith K, Baker M, Waipara N. Retrofitting houses with insulation to reduce health inequalities: aims and methods of a clustered, randomis — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Self reported general health, During the first winter post intervention
Primary Indoor temperature and relative humidity, During the first winter post intervention
Secondary Energy consumption, During the first winter post intervention
Secondary Wheezing, During the first winter post intervention
Secondary Days off school and work, During the first winter post intervention
Secondary GP visits, During the first winter post intervention
Secondary Inpatient hospital admissions, During the first winter post intervention
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device

External Links